BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-07-20: Reporting owner Dobroff Lawrence; Form 4; Security BioSpecifics Technologies Corp; Transaction S Open market or private sale of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-07-20 | Dobroff Lawrence Officer (Chief Financial Offiicer) | 4 | BioSpecifics Technologies Corp Non-derivative · Direct | S Open market or private sale of non-derivative or derivative security | −10,000 0 owned after | $0.96 | 2006-08-07 |